Traditional anti-ageing skincare uses retinoids, acids, and peptides to address visible symptoms at the skin’s surface, while neurocosmetics works at the neurological layer beneath that, targeting the skin-brain axis, the HPA axis, and ion channels like TRPV1 to address the biological signals that drive ageing at its source. The distinction matters most for women over 40, where chronic stress, hormonal shifts, and neurogenic inflammation are often the actual reasons conventional products stop delivering the results they once did.
What does traditional anti-ageing skincare actually do to the skin?
Traditional anti-ageing skincare operates on a well-mapped but surface-level model. Retinoids accelerate cell turnover and stimulate collagen production. Hyaluronic acid draws moisture into the epidermis. Peptides like Matrixyl send signals to fibroblasts to produce more collagen and elastin. These are real, measurable mechanisms, but they treat the skin as an isolated organ, responding to topical chemistry without accounting for the neurological signals that regulate it.
Traditional approaches like retinoids and hyaluronic acid have been effective to some extent but often come with limitations, including irritation and limited long-term efficacy. Retinol, for instance, can show initial surface-level changes in two to four weeks, but the irritation it causes in dry or sensitive skin is a known trade-off. Peptides are gentler, but even well-formulated peptide creams can struggle with penetration, sitting on the surface rather than reaching the dermal layer where the most significant ageing processes occur.
None of these ingredients address what is happening upstream: the stress hormones, neuropeptides, and ion channel activity that determine how the skin behaves at a cellular level day after day.
How does the skin-brain axis change the way we understand ageing?
The skin and the brain originate from the same embryonic layer, the ectoderm. A 2025 review published in Clinics in Dermatology confirmed that bidirectional communication between the skin and brain has emerged as a credible scientific paradigm, not a marketing claim, and the implications for how we think about ageing are significant.
This communication runs through several pathways. The hypothalamic-pituitary-adrenal (HPA) axis is one of the most studied. When psychological or environmental stress activates it, the brain and pituitary release corticotropin-releasing hormone and adrenocorticotropic hormone, the adrenal glands secrete cortisol, and peripheral nerves release neuropeptides including Substance P and calcitonin gene-related peptide. These signals land directly on the skin. Excessive cortisol secretion and elevated neuropeptide levels cause dysregulation of the skin’s immune response, impaired barrier function, and pathological inflammation.
Critically, the skin also carries its own peripheral version of this axis. Keratinocytes, mast cells, sebocytes, and melanocytes locally produce the same hormones that circulate from the brain, meaning the skin does not simply receive stress signals: it amplifies them from within.
What are TRPV1 channels and why do they matter for women over 40?
TRPV1 (transient receptor potential vanilloid 1) is a non-selective ion channel receptor widely expressed in skin tissues, including keratinocytes, peripheral sensory nerve fibres, and immune cells. It is activated by inflammatory mediators, UV radiation, and heat, and when it fires, it triggers neuropeptide release and a neurogenic inflammatory response. Research has shown that TRPV1 is closely linked to the development of skin ageing and chronic inflammatory skin conditions including rosacea and atopic dermatitis.
The ageing dimension is specific: TRPV1 protein expression is measurably higher in the skin of elderly subjects than in young people, and UV irradiation increases TRPV1 expression further. The downstream signalling pathways of TRPV1 and calcium ions are directly involved in UV-induced skin ageing, partly by increasing the expression of MMP-1, a matrix metalloproteinase that degrades collagen. Where a standard retinol serum addresses collagen loss after the fact, a neurocosmetic formulation designed to modulate TRPV1 can intervene earlier in that cascade.
What role do neuropeptides like oxytocin play in skin ageing?
Neuropeptides are chemical messengers between nerves and skin cells, and their role in ageing is increasingly well documented. Oxytocin is among the most studied. Research published in the British Journal of Dermatology showed that oxytocin is a neuropeptide hormone with protective effects against age-related disorders, and that it alleviates dermal fibroblast senescence. Pilot clinical data found that higher oxytocin levels correlated with more youthful-looking skin as measured by skin age score, even in women aged 48 to 61 with significant sun exposure histories.
The mechanism is specific: fibroblasts express oxytocin receptors, and when oxytocin binds to those receptors, it suppresses the senescence-associated secretory phenotype (SASP), an array of pro-inflammatory cytokines and extracellular matrix-degrading proteases that accelerate visible ageing. OXTR expression in fibroblasts also declines with donor age, suggesting that declining oxytocin signalling may be one reason skin ages faster after 40. Conventional skincare does not target this pathway at all.
Other neuropeptides, including Substance P and calcitonin gene-related peptide, are implicated in skin inflammation when the HPA axis is chronically activated. Neurocosmetics approaches these as upstream targets rather than treating the inflammation they cause after the fact.
The Skin-Brain Axis Is the Missing Variable in Anti-Ageing
If you have used good conventional skincare consistently and still find your results plateauing, the skin-brain axis is probably the variable that has not been addressed. The global neurocosmetics market was estimated at USD 1.94 billion in 2024 and is growing at 8.5% annually through 2030, reflecting clinical and consumer recognition that neurological pathways matter in skincare outcomes, growth driven by a genuine clinical gap, not novelty.
Justhuman is India’s first neurocosmetics brand built specifically around this gap. Its formulations are designed to activate the skin’s neuroreceptors, including oxytocin signalling pathways, and are free from over 900 chemicals listed under California Prop 65. For women over 40 who want more than surface-level correction, the Daily Sensation Cream is formulated around oxytocin signalling to address the fibroblast senescence and neurological dimension of ageing that conventional products miss.
Frequently Asked Questions
Is neurocosmetics scientifically proven or is it mostly marketing?
Neurocosmetics is grounded in peer-reviewed dermatology and psychodermatology research. A 2025 review in Clinics in Dermatology confirmed the skin-brain axis as a credible scientific paradigm. TRPV1’s role in skin ageing and oxytocin’s effect on fibroblast senescence are both documented in indexed journals. The field is still maturing, but its biological foundations are not speculative.
Can I use neurocosmetic products alongside my existing retinol or peptide routine?
Yes, in most cases neurocosmetic products complement rather than replace conventional actives. They operate on different biological pathways: retinoids work on cell turnover and gene transcription, while neurocosmetics target neuroreceptors and neuropeptide signalling. Using both means addressing ageing at the surface level and at the neurological level simultaneously.
Why does skin ageing accelerate so noticeably after 40 even with a good skincare routine?
After 40, hormonal shifts reduce oestrogen and oxytocin levels, the HPA axis becomes more reactive to stress, and TRPV1 expression in the skin increases with cumulative UV exposure. These neurological and endocrine changes mean the skin’s internal regulatory environment is less stable, and surface-only products cannot compensate for that shift. Addressing the skin-brain axis becomes more relevant, not less, as you age.
What ingredients should I look for in a genuinely neurocosmetic formulation?
Look for ingredients that interact with neuroreceptors rather than just the extracellular matrix. Oxytocin-activating compounds, neuropeptides that modulate Substance P or CGRP, and TRPV1-calming actives are the categories to prioritise. Delivery system quality also matters: neuroactive molecules need to reach the dermal layer to engage the receptors they target.
How is neurocosmetics different from psychodermatology?
Psychodermatology is the clinical field that studies how psychological states affect skin disease, primarily in a medical context. Neurocosmetics applies the same biological understanding to cosmetic formulation, designing products that interact with the skin’s nervous system. A psychodermatologist treating stress-triggered rosacea would prescribe medication or therapy; a neurocosmetics formulator would design a topical to calm TRPV1 activity and reduce neurogenic inflammation at the skin surface. One diagnoses and treats; the other formulates.
